
Overview
Akademia Boreliozy publishes educational material about Lyme disease, its diagnosis, symptoms, co-infections and effects on children. It also covers antibiotics, phytotherapy, parasites, detoxification, diet and supplements.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-03-01. Active
82 1090 1418 0000 0001 3584 5286
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $483$483 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $238$238 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $298$298 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Trademarks
Akademia Boreliozy holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2018.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| ab AKADEMIA BORELIOZY | Z.484401 | 3, 5, 25, 41, 42, 44 | Protected | Apr 3, 2028 |
| Mark | Protected until | |
|---|---|---|
| ab AKADEMIA BORELIOZY | Apr 3, 2028 |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, one member of the management board is authorised to represent the company independently. If the management board is a multi-member management board, the company is represented by two members of the management board acting jointly or by one member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Akademia Boreliozy Sp. z o.o. | 20 | $540.25 | 25% |
Damian Marek Urbaniak (50) | 33 | $891.41 | 41.25% |
Others | 27 | $729.34 | 33.75% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Botanical & Medicinal Researchsp. z o.o. | 1,080.50 USD | 80% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PLON Pharmsp. z o.o. | $524,792.98 | plonpharm.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| Biovitalium Polskasp. z o.o. | $95,895.45 | biovitalium.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $48,959.05 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-03-08 | Address change (Ul. Kaliska 22, 63-460, Kotowiecko → Ul. Plac Niepodległości 15, 62-035, Kórnik) | |
| 2018-02-12 | Entered in the register |
FAQ
Last updated: 2026-07-09